Results 81 to 90 of about 1,923,312 (279)

Honey as an antiviral agent against respiratory syncytial virus [PDF]

open access: yes, 2011
Respiratory syncytial virus is the most frequent cause of hospitalization for viral respiratory infections in infants and young children worldwide. It also severely affects immunocompromised adults and the elderly, however, despite decades of efforts ...
Zareie, Parvaneh Palma
core  

Bridging the translational gap in clinical nanomedicine: From rational design to clinical reality

open access: yesBMEMat, EarlyView.
Nanotechnology offers a multi‐faceted approach to modern healthcare, encompassing high‐sensitivity diagnostic imaging, innovative vaccine delivery, and targeted therapeutics. This review explores how these nanomedicine applications address critical challenges in cancer recurrence and the treatment of neurologic and respiratory diseases to combat rising
Ahmed H. Ghonaim   +9 more
wiley   +1 more source

Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies

open access: yesHaematologica, 2019
In the USA and other western nations, respiratory syncytial virus is one of the most commonly encountered respiratory viruses among patients who have been diagnosed with a hematologic malignancy or who have undergone a stem cell transplant.
Fareed Khawaja, Roy F. Chemaly
doaj   +1 more source

A White Paper on Advancing Long‐Acting Therapeutics for Maternal and Pediatric Health by Bridging Gaps in Clinical Research, Access and Regulation

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
As use cases for long‐acting therapeutics expand across clinical indications, there is a critical need to ensure the inclusion of women who are pregnant or breastfeeding, infants and children—populations with a historical gap in the availability of interventions already approved for use in adults.
Moherndran Archary   +59 more
wiley   +1 more source

The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada: A population-based study

open access: yesThe Lancet Regional Health - Americas, 2021
Background The ongoing coronavirus disease 2019 (COVID-19) pandemic has resulted in implementation of public health measures worldwide to mitigate disease spread, including; travel restrictions, lockdowns, messaging on handwashing, use of face coverings ...
H. Groves   +9 more
semanticscholar   +1 more source

Long‐Acting Therapeutics in Pediatric Health: Bridging Innovation and Access

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Children have distinct therapeutic needs arising from age‐dependent physiology, disease epidemiology, formulation requirements, dosing considerations, and safety vulnerabilities. Despite substantial reductions in childhood mortality over the past three decades, nearly 5 million children under five died in 2023, with infectious diseases continuing to ...
Prajith Venkatasubramanian   +5 more
wiley   +1 more source

Respiratory Syncytial Virus–Associated Hospitalizations Among Young Children: 2015–2016

open access: yesPediatrics, 2020
In this active, prospective, multicenter, population-based surveillance study, we provide updated estimates of RSV hospitalization burden among US children
B. Rha   +31 more
semanticscholar   +1 more source

Respiratory Syncytial Virus Vaccination During Pregnancy and Effects in Infants

open access: yesObstetrical and Gynecological Survey, 2021
METHODS Healthy pregnant women, at 28 weeks 0 days through 36 weeks 0 days of gestation, with an expected delivery date near the start of the RSV season, were randomly assigned in an overall ratio of approximately 2:1 to receive a single intramuscular ...
S. Madhi   +51 more
semanticscholar   +1 more source

Revolutionizing Healthcare With Paper‐Based Nucleic Acid Testing

open access: yesExploration, EarlyView.
This work summarizes strategies to enhance paper‐based devices for nucleic acid testing. Key approaches include optimizing paper platforms, improving nucleic acid amplification, and refining labeling/signaling methods. These advancements aim to boost sensitivity, speed, and usability, making paper‐based diagnostics more effective for point‐of‐care ...
Hong Zhang   +8 more
wiley   +1 more source

Use of Ribavirin treatment in Pre-transplant patients with Respiratory Syncytial Virus Upper Respiratory Tract Infection: Case report and Review of Literature

open access: yesJournal of Pediatrics Review, 2014
Respiratory syncytial virus infection in patients undergoing haematopoetic stem cell transplantation can be associated with high morbidity and mortality.
Ameneh Khatami
doaj  

Home - About - Disclaimer - Privacy